Monique Breslin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Monique Breslin has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
- Michele Callisaya
University of Tasmania
6 shared publications - Amanda Louise Neil
Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia
5 shared publications - Kristy Sanderson
University of East Anglia
5 shared publications - Seana L. Gall
Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia
5 shared publications - Barbara de Graaff
Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia
3 shared publications Coralie English
School of Health Sciences, University of Newcastle, Newcastle, Australia
3 shared publications
Latest Publications
- 1 October 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (10)
Explaining Variance in Pulse Wave Velocity in Youth: The Youth Vascular Consortium
BACKGROUND: Cardiovascular disease is a leading cause of global mortality. Carotid-femoral pulse wave velocity (cfPWV) is the gold-standard noninvasive measure of arterial stiffness and is commonly used to assess early vascular aging, as it predicts future cardiovascular events. Although the influence of cardiovascular risk factors on cfPWV is well studied in adults, evidence in youth is limited. This study aimed to identify common cardiovascular risk factors that best explain variation in cfPWV among young people. METHODS: This study included 6763 participants aged 5 to 40 years with cfPWV measured using the SphygmoCor device, drawn from the Youth Vascular Consortium. Analyses were conducted across 5 subsets based on data completeness. Multiple linear regression models, stratified by sex and age (≤19 and >19 years), were developed to identify cardiovascular risk factors explaining cfPWV variation. Model selection was guided by Akaike information criterion and adjusted R 2 . RESULTS: Age and systolic blood pressure were consistent predictors, explaining <40% of cfPWV variance in cfPWV. Heart rate and waist circumference also emerged as key predictors of cfPWV, although lipids contributed modestly only in young adults. Waist circumference was the strongest anthropometric predictor in most groups. CONCLUSIONS: Age, systolic blood pressure, and heart rate were the strong contributors among traditional risk factors, yet explained <40% of variance in cfPWV in most groups. These findings highlight the role of hemodynamic load in shaping arterial stiffness even in childhood and adolescence, when structural changes are evolving. A large proportion of variance remains unexplained, suggesting that genetic, prenatal, environmental, and behavioral factors warrant investigation.
- 1 October 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (10)
Explaining Variance in Pulse Wave Velocity in Youth: The Youth Vascular Consortium
BACKGROUND: Cardiovascular disease is a leading cause of global mortality. Carotid-femoral pulse wave velocity (cfPWV) is the gold-standard noninvasive measure of arterial stiffness and is commonly used to assess early vascular aging, as it predicts future cardiovascular events. Although the influence of cardiovascular risk factors on cfPWV is well studied in adults, evidence in youth is limited. This study aimed to identify common cardiovascular risk factors that best explain variation in cfPWV among young people. METHODS: This study included 6763 participants aged 5 to 40 years with cfPWV measured using the SphygmoCor device, drawn from the Youth Vascular Consortium. Analyses were conducted across 5 subsets based on data completeness. Multiple linear regression models, stratified by sex and age (≤19 and >19 years), were developed to identify cardiovascular risk factors explaining cfPWV variation. Model selection was guided by Akaike information criterion and adjusted R 2 . RESULTS: Age and systolic blood pressure were consistent predictors, explaining <40% of cfPWV variance in cfPWV. Heart rate and waist circumference also emerged as key predictors of cfPWV, although lipids contributed modestly only in young adults. Waist circumference was the strongest anthropometric predictor in most groups. CONCLUSIONS: Age, systolic blood pressure, and heart rate were the strong contributors among traditional risk factors, yet explained <40% of variance in cfPWV in most groups. These findings highlight the role of hemodynamic load in shaping arterial stiffness even in childhood and adolescence, when structural changes are evolving. A large proportion of variance remains unexplained, suggesting that genetic, prenatal, environmental, and behavioral factors warrant investigation.
- 26 June 2026
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 113, 107345
Does laughter yoga really improve fatigue, sleep quality and psychological wellbeing in people living with MS?
- 26 June 2026
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 113, 107345
Does laughter yoga really improve fatigue, sleep quality and psychological wellbeing in people living with MS?
- Open Access
- 11 March 2026
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 109, 107136
Do sleep interventions improve sleep in MS? A systematic review and meta-analysis of activity monitor assessed outcomes
- 11 March 2026
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 109, 107136
Open AccessDo sleep interventions improve sleep in MS? A systematic review and meta-analysis of activity monitor assessed outcomes
- Top Cited Papers
- 1 July 2025
- Published by Wolters Kluwer Health in Hypertension
- Vol. 82 (7) , 1234-1245
Establishing Reference Values for Pulse Wave Velocity in Young People: The Youth Vascular Consortium
BACKGROUND: Aortic pulse wave velocity (PWV) is an indicator of vascular aging and has proven to be effective in adult cardiovascular risk assessment. To use it in young people to identify those who may be at increased cardiovascular disease risk, reference values need to be determined. The Youth Vascular Consortium is a large, international database which was established to investigate vascular aging in youth. Using data from the Youth Vascular Consortium, this study aimed to develop reference values for aortic PWV in healthy young people. METHODS: This is a retrospective, multicenter study. Data on demographics, anthropometric, biochemical, and vascular aging measures from participants aged 1 year to 40 years were harmonized. Generalized additive models were used to derive percentile curves for PWV and predicted percentiles at years of age were reported by sex, continent, and device. RESULTS: Data from 19 930 participants (mean age=17 years, 51% women, 71% European), classified as healthy based on blood pressure, body mass index, serum glucose, and cholesterol levels, were included to construct the reference values. Six devices were used to assess aortic PWV (29% SphygmoCor). Device-specific percentile curves for aortic PWV were constructed, and an increasing trend was identified for both sexes with age. CONCLUSIONS: This study provided reference values for aortic PWV assessed with 6 devices for healthy young people by age and sex. These percentiles may be applied clinically to identify youth with impaired vascular aging and, thus, those who may be at risk of developing overt cardiovascular disease in the future.
- 1 July 2025
- Published by Wolters Kluwer Health in Hypertension
- Vol. 82 (7) , 1234-1245
Top Cited PapersEstablishing Reference Values for Pulse Wave Velocity in Young People: The Youth Vascular Consortium
BACKGROUND: Aortic pulse wave velocity (PWV) is an indicator of vascular aging and has proven to be effective in adult cardiovascular risk assessment. To use it in young people to identify those who may be at increased cardiovascular disease risk, reference values need to be determined. The Youth Vascular Consortium is a large, international database which was established to investigate vascular aging in youth. Using data from the Youth Vascular Consortium, this study aimed to develop reference values for aortic PWV in healthy young people. METHODS: This is a retrospective, multicenter study. Data on demographics, anthropometric, biochemical, and vascular aging measures from participants aged 1 year to 40 years were harmonized. Generalized additive models were used to derive percentile curves for PWV and predicted percentiles at years of age were reported by sex, continent, and device. RESULTS: Data from 19 930 participants (mean age=17 years, 51% women, 71% European), classified as healthy based on blood pressure, body mass index, serum glucose, and cholesterol levels, were included to construct the reference values. Six devices were used to assess aortic PWV (29% SphygmoCor). Device-specific percentile curves for aortic PWV were constructed, and an increasing trend was identified for both sexes with age. CONCLUSIONS: This study provided reference values for aortic PWV assessed with 6 devices for healthy young people by age and sex. These percentiles may be applied clinically to identify youth with impaired vascular aging and, thus, those who may be at risk of developing overt cardiovascular disease in the future.
- Open Access
- 5 June 2025
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 101, 106565
Treatments used by people living with MS to get to sleep or stay asleep, and impacts on sleep quality and daytime sleepiness
- 5 June 2025
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 101, 106565
Open AccessTreatments used by people living with MS to get to sleep or stay asleep, and impacts on sleep quality and daytime sleepiness
- 15 February 2024
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 35 (5) , 793-811
Considering endpoints for comparative tolerability of cancer treatments using patient report given the estimand framework
Regulatory agencies are advancing the use of systematic approaches to collect patient experience data, including patient-reported outcomes (PROs), in cancer clinical trials to inform regulatory decision-making. Due in part to clinician under-reporting of symptomatic adverse events, there is a growing recognition that evaluation of cancer treatment tolerability should include the patient experience, both in terms of the overall side effect impact and symptomatic adverse events. Methodologies around implementation, analysis, and interpretation of "patient" reported tolerability are under development, and current approaches are largely descriptive. There is robust guidance for use of PROs as efficacy endpoints to compare cancer treatments, but it is unclear to what extent this can be relied-upon to develop tolerability endpoints. An important consideration when developing endpoints to compare tolerability between treatments is the linkage of trial design, objectives, and statistical analysis. Despite interest in and frequent collection of PRO data in oncology trials, heterogeneity in analyses and unclear PRO objectives mean that design, objectives, and analysis may not be aligned, posing substantial challenges for the interpretation of results. The recent ICH E9 (R1) estimand framework represents an opportunity to help address these challenges. Efforts to apply the estimand framework in the context of PROs have primarily focused on efficacy outcomes. In this paper, we discuss considerations for comparing the patient-reported tolerability of different treatments in an oncology trial context.
- 15 February 2024
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 35 (5) , 793-811
Considering endpoints for comparative tolerability of cancer treatments using patient report given the estimand framework
Regulatory agencies are advancing the use of systematic approaches to collect patient experience data, including patient-reported outcomes (PROs), in cancer clinical trials to inform regulatory decision-making. Due in part to clinician under-reporting of symptomatic adverse events, there is a growing recognition that evaluation of cancer treatment tolerability should include the patient experience, both in terms of the overall side effect impact and symptomatic adverse events. Methodologies around implementation, analysis, and interpretation of "patient" reported tolerability are under development, and current approaches are largely descriptive. There is robust guidance for use of PROs as efficacy endpoints to compare cancer treatments, but it is unclear to what extent this can be relied-upon to develop tolerability endpoints. An important consideration when developing endpoints to compare tolerability between treatments is the linkage of trial design, objectives, and statistical analysis. Despite interest in and frequent collection of PRO data in oncology trials, heterogeneity in analyses and unclear PRO objectives mean that design, objectives, and analysis may not be aligned, posing substantial challenges for the interpretation of results. The recent ICH E9 (R1) estimand framework represents an opportunity to help address these challenges. Efforts to apply the estimand framework in the context of PROs have primarily focused on efficacy outcomes. In this paper, we discuss considerations for comparing the patient-reported tolerability of different treatments in an oncology trial context.
- 1 January 2022
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 31 (1) , 106201
Case-Fatality and Functional Outcome after Subarachnoid Hemorrhage (SAH) in INternational STRoke oUtComes sTudy (INSTRUCT)
- 1 January 2022
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 31 (1) , 106201
Case-Fatality and Functional Outcome after Subarachnoid Hemorrhage (SAH) in INternational STRoke oUtComes sTudy (INSTRUCT)
- 29 April 2021
- Published by Springer Nature in Brain Topography
- Vol. 34 (4) , 478-488
The Associations Between Grey Matter Volume Covariance Patterns and Gait Variability—The Tasmanian Study of Cognition and Gait
Greater gait variability predicts dementia. However, little is known about the neural correlates of gait variability. The aims of this study were to determine (1) grey matter volume covariance patterns associated with gait variability and (2) whether these patterns were associated with specific cognitive domains. Participants (n = 351; mean age 71.9 ± 7.1) were randomly selected from the Southern Tasmanian electoral roll. Step time, step length, step width and double support time were measured using an electronic walkway. Gait variability was calculated as the standard deviation of all steps for each gait measure. Voxel-based morphometry and multivariate covariance-based analyses were used to identify grey matter patterns associated with each gait variability measure. The individual expressions of grey matter patterns were correlated with processing speed, memory, executive and visuospatial functions. The grey matter covariance pattern of double support time variability included frontal, medial temporal, anterior cingulate, insula, cerebellar and striatal regions. Greater expression of this pattern was correlated with poorer performance in all cognitive functions (p < 0.001). The covariance pattern of step length variability included frontal, temporal, insula, occipital and cerebellar regions and was correlated with all cognitive functions (p < 0.05), except memory (p = 0.76). The covariance pattern of step width variability was limited to the cerebellum and correlated only with memory (p = 0.047). No significant pattern was identified for step time variability. In conclusion, different grey matter covariance patterns were associated with individual gait variability measures. These patterns were also correlated with specific cognitive functions, suggesting common neural networks may underlie both gait and cognition.
- 29 April 2021
- Published by Springer Nature in Brain Topography
- Vol. 34 (4) , 478-488
The Associations Between Grey Matter Volume Covariance Patterns and Gait Variability—The Tasmanian Study of Cognition and Gait
Greater gait variability predicts dementia. However, little is known about the neural correlates of gait variability. The aims of this study were to determine (1) grey matter volume covariance patterns associated with gait variability and (2) whether these patterns were associated with specific cognitive domains. Participants (n = 351; mean age 71.9 ± 7.1) were randomly selected from the Southern Tasmanian electoral roll. Step time, step length, step width and double support time were measured using an electronic walkway. Gait variability was calculated as the standard deviation of all steps for each gait measure. Voxel-based morphometry and multivariate covariance-based analyses were used to identify grey matter patterns associated with each gait variability measure. The individual expressions of grey matter patterns were correlated with processing speed, memory, executive and visuospatial functions. The grey matter covariance pattern of double support time variability included frontal, medial temporal, anterior cingulate, insula, cerebellar and striatal regions. Greater expression of this pattern was correlated with poorer performance in all cognitive functions (p < 0.001). The covariance pattern of step length variability included frontal, temporal, insula, occipital and cerebellar regions and was correlated with all cognitive functions (p < 0.05), except memory (p = 0.76). The covariance pattern of step width variability was limited to the cerebellum and correlated only with memory (p = 0.047). No significant pattern was identified for step time variability. In conclusion, different grey matter covariance patterns were associated with individual gait variability measures. These patterns were also correlated with specific cognitive functions, suggesting common neural networks may underlie both gait and cognition.
- 5 January 2021
- Published by Taylor & Francis in Disability and Rehabilitation
- Vol. 44 (14) , 3501-3509
“Factors influencing sedentary time and physical activity early after stroke: a qualitative study”
We aimed to understand from the perspective of stroke survivors and their carers (1) factors contributing to sedentary time and physical activity during inpatient rehabilitation and the transition ...
- 5 January 2021
- Published by Taylor & Francis in Disability and Rehabilitation
- Vol. 44 (14) , 3501-3509
“Factors influencing sedentary time and physical activity early after stroke: a qualitative study”
We aimed to understand from the perspective of stroke survivors and their carers (1) factors contributing to sedentary time and physical activity during inpatient rehabilitation and the transition ...
- 1 October 2020
- Published by Elsevier in Gait & Posture
- Vol. 82, 174-180
The associations between dual-task walking under three different interference conditions and cognitive function
- 1 October 2020
- Published by Elsevier in Gait & Posture
- Vol. 82, 174-180
The associations between dual-task walking under three different interference conditions and cognitive function